Data Demonstrates that Test Can Identify Cancer Early Through Analysis of Blood MUKILTEO, Wash., Feb. 26, 2009 -- CombiMatrix Corporation (NasdaqGM:CBMX - News) today announced positive preliminary data on its investigational Comprehensive Cancer Array (CCA) test showing it can non-invasively screen for the early detection of cancer. The study focused on prostate, colon, ovarian, breast, [...]

MADISON, Wis.--Promega Corporation announces the availability of the new pmirGLO Dual-Luciferase miRNA Target Expression Vector. pmirGLO supports both breadth and depth in the microRNA study. Researchers have both ability to measure a wide dynamic range of miRNA activity in a vast number of cell types and the option to create a stable cell line from [...]

KNOXVILLE, TN--(February 26, 2009) - Protein Discovery, Inc., a privately held life sciences company, today announced that it has hired Jeffrey A. Komatz for the position of chief financial officer. Mr. Komatz will be responsible for ensuring the continued financial health of Protein Discovery. As the CFO, Mr. Komatz will plan and manage the company's [...]

FLORENCE, S.C., Feb. 26 -- Pathology Service Associates, LLC (PSA), a MED3OOO Company, the country's leading provider of revenue cycle management and other support services to independent pathologists across the United States, has entered into a Business Alliance Agreement with Fisher Healthcare, a part of Thermo Fisher Scientific, Inc. PSA's Business Alliance Program enables PSA-affiliated [...]

HERCULES, CA – February 26, 2009 – Bio-Rad Laboratories, Inc, (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the company, Novartis Institutes for BioMedical Research and Nonlinear Dynamics are coordinating the proteomics community's efforts to develop standards and validated protocols that will ensure reproducibility [...]

CARLSBAD, Calif.--Helixis, Inc., developer of nucleic acid analysis tools, announced today that Jay Flatley, CEO of Illumina, Inc., has joined the company’s board of directors. Under Flatley’s leadership Illumina has become the market leader in genotyping and next-generation sequencing systems, and has completed numerous strategic technology acquisitions. Recognizing the company’s record of growth, Forbes magazine [...]

BioTime, Inc., (OTCBB:BTIM) announced today that its wholly-owned subsidiary Embryome Sciences, Inc. has entered into an agreement with Reproductive Genetics Institute (RGI) of Chicago, Illinois granting Embryome Sciences rights to market new human embryonic stem cell (hES) lines selected by Embryome Sciences from 294 hES lines derived by RGI. Embryome Sciences will initially select 10 [...]

MADISON, Wis.--The NMD-Chip Consortium, an initiative of the Seventh Framework Programme for Research and Technological Development, recently selected Roche NimbleGen microarrays to accelerate and simplify genetic research of neuromuscular disorders (NMDs). The NMD-Chip Consortium is comprised of 13 European entities from eight countries whose goal is to further our understanding of NMDs and to investigate [...]

SAN FRANCISCO, CAMBRIDGE, Mass. and GAITHERSBURG, Md., Feb. 25 -- (CHI's Molecular Medicine Tri-Conference) - Genstruct Inc., a systems biology company focused on identifying molecular mechanisms, networks and biomarkers to better develop novel therapeutics, molecular diagnostics and patient-specific therapies, today announced that it has signed a partnership agreement with Gene Logic, an Ocimum Biosolutions company, [...]

Comprehensive Mycotoxin Screen Enables Compliance with New Regulations at Lower Cost MOUNTAIN VIEW, Calif.--Pickering Laboratories today announced that researchers at the Munich Technical University and Bavarian Health and Food Safety Authority have developed an innovative, comprehensive mycotoxin screening method based on the use of LCTech’s GPC ULTRA gel permeation chromatography instrument. Distributed by Pickering Laboratories [...]